PUBLICATION

Fucoidan But Not 2'-Fucosyllactose Inhibits Human Norovirus Replication in Zebrafish Larvae

Authors
Tan, M.T.H., Li, Y., Eshaghi Gorji, M., Gong, Z., Li, D.
ID
ZDB-PUB-210407-14
Date
2021
Source
Viruses   13(3): (Journal)
Registered Authors
Gong, Zhiyuan
Keywords
2′-fucosyllactose, antiviral, fucoidan, norovirus
MeSH Terms
  • Animals
  • Antiviral Agents/pharmacology*
  • Humans
  • Larva/virology
  • Norovirus/drug effects
  • Norovirus/growth & development*
  • Polysaccharides/pharmacology*
  • Saliva/virology
  • Trisaccharides/pharmacology*
  • Virus Attachment/drug effects
  • Virus Replication/drug effects
  • Zebrafish/embryology
  • Zebrafish/virology*
PubMed
33799811 Full text @ Viruses
Abstract
Human noroviruses (hNoVs) cause heavy disease burden worldwide and there is no clinically approved vaccination or antiviral hitherto. In this study, with the use of a zebrafish larva in vivo platform, we investigated the anti-hNoV potentials of fucoidan (from brown algae Fucus vesiculosus) and 2'-Fucosyllactose (2'-FL). As a result, although both fucoidan and 2'-FL were able to block hNoV GII.4 virus-like particle (VLPs) from binding to type A saliva as expected, only fucoidan, but not 2'-FL, was able to inhibit the replication of hNoV GII.P16-GII.4 in zebrafish larvae, indicating the possible needs of higher molecular weights for fucosylated carbohydrates to exert anti-hNoV effect.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping